AI-Powered Solutions Across Clinical Development and Commercialization
Artificial intelligence is reshaping every phase of the biopharmaceutical journey, and Syneos Health is well-positioned to translate that potential into measurable outcomes. As a fully integrated biopharmaceutical solutions organization, we are applying AI and machine learning across clinical development and commercialization to help customers move faster, make smarter decisions and bring therapies to patients more efficiently. From AI-driven patient recruitment and protocol optimization to predictive analytics for commercial launch planning and market access, our work spans the full drug development continuum.
Our Leadership
Mike Montello
Chief Digital and Information Officer
Stephen Hoelper
Global Head, Commercial Product
Matt Harrington
Global Head, Clinical Product
AI Careers at Syneos Health
Building our AI capabilities in the workforce
Skills Accelerator
Discover how the Syneos Health Skills Accelerator Program is building an AI‑ready workforce. Through practical, role‑based learning and enterprise‑approved AI tools, the program helps teams deliver faster insights, higher quality and more consistent performance across clinical and commercial delivery.
Digital Edge Program
Digital Edge at Syneos Health is a skills development program focused on building digital fluency and role‑specific AI capabilities, helping teams work smarter, innovate faster and deliver greater customer impact.
Our AI Hub in Hyderabad
The Syneos Health Hyderabad AI Hub delivers production‑ready AI for clinical development, patient safety and life sciences innovation by combining deep biopharma expertise with scalable, responsible AI built for regulated environments.
View our open roles in the AI field.
FEATURED ROLE
Director, AI Solutions
Madhapur, TS, India
The Director of AI Solutions – Clinical Research & Trials will lead the strategy, design and implementation of AI-driven solutions to accelerate clinical trial operations, enhance patient recruitment and retention, optimize protocol design and improve data quality and compliance. This role requires a visionary leader with deep expertise in artificial intelligence, machine learning and clinical research processes, combined with strong knowledge of regulatory frameworks (ICH-GCP, FDA, EMA). The Director will collaborate with sponsors, CRO teams and technology partners to deliver scalable, compliant and innovative AI solutions that reduce trial timelines and costs while improving patient outcomes.
Thought Leadership in AI
Looking for exclusive insight?
Come see us at an upcoming event
DIA (Drug Information Association) Annual Meeting
June 14-15, 2026 | Philadelphia, PA
Click here to book a meeting.
